Daridorexant, Idorsia’s dual orexin receptor antagonist, shows consistent efficacy across both insomnia- and nocturia-related endpoints in a placebo-controlled study in patients with chronic insomnia ...

Daridorexant, a dual orexin receptor antagonist, is currently approved for the treatment of adult patients with insomnia, characterized by difficulties with sleep onset and/or sleep maintenance.

Kidney failure is an insidious danger but being aware of the early warnings will avoid permanent damage Read ahead to know ...

Daridorexant, Idorsia's dual orexin receptor antagonist, shows consistent efficacy across both insomnia- and nocturia-related endpoints in a placebo-controlled study in patients with chronic insomnia ...

Idorsia Ltd (SIX: IDIA) today announced the publication of "A randomized cross-over trial of daridorexant for the treatment of chronic insomnia and nocturia” in the Journal of Sleep Research. The new ...

The study, named A randomized cross-over trial of daridorexant for the treatment of chronic insomnia and nocturia, is a ...

Millions of people will be experiencing the same problem - and there are often valid reasons to explain what's happening and ...

72% of respondents who suffer from sleep interruptions blame nocturnal visits to the washroom. Other disturbances include ...

There is generally a moment in my office when it all clicks into focus for a patient receiving a new diagnosis of ...

But if your sleep is ruined by needing to pee constantly throughout the night, you're not alone. If you want to get quality ...

Survey by LocalCircles collected over 43,000 responses from 348 districts. Sixty-one percent of the respondents were men ...